Differential Induction of Functional IgG Using the Plasmodium falciparum Placental Malaria Vaccine Candidate VAR2CSA
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In Plasmodium falciparum malaria endemic areas placental malaria (PM) is an important complication of malaria. The recurrence of malaria in primigravidae women irrespective of acquired protection during childhood is caused by the interaction between the parasite-expressed VAR2CSA antigen and chondroitin sulfate A (CSA) in the placental intervillous space and lack of protective antibodies. PM impairs fetal development mainly by excessive inflammation processes. After infections during pregnancy women acquire immunity to PM conferred by antibodies against VAR2CSA. Ideally, a vaccine against PM will induce antibody-mediated immune responses that block the adhesion of infected erythrocytes (IE) in the placenta. PRINCIPAL FINDINGS: We have previously shown that antibodies raised in rat against individual domains of VAR2CSA can block IE binding to CSA. In this study we have immunized mice, rats and rabbits with each individual domain and the full-length protein corresponding to the FCR3 VAR2CSA variant. We found there is an inherently higher immunogenicity of C-terminal domains compared to N-terminally located domains. This was irrespective of whether antibodies were induced against single domains or the full-length protein. Species-specific antibody responses were also found, these were mainly directed against single domains and not the full-length VAR2CSA protein. CONCLUSIONS/SIGNIFICANCE: Binding inhibitory antibodies appeared to be against conformational B-cell epitopes. Non-binding inhibitory antibodies reacted highly against the C-terminal end of the VAR2CSA molecule especially the highly polymorphic DBL6ε domain. Differential species-specific induction of antibody responses may allow for more direct analysis of functional versus non-functional B-cell epitopes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Comparison of surface reactivity and inhibition of FCR3-IE adhesion to CSPG. (A) Anti-VAR2CSA serum from rats and rabbits raised against DBL1X-DBL6ε and FV2 were tested using FCR3-IE for the ability of serum used in a 1∶10 dilution to inhibit binding to CSA in a 96-well plate assay. The data shown are the ratios of binding compared to the negative DBL3γVAR1 control ((Binding [test sample])/(Binding [negative control])). (B) IgG was purified from selected inhibitory and non-inhibitory sera and tested for reactivity in FACS at 1 mg/ml. DBL3γVAR1 was used as negative control. (C) Inhibition of binding to CSA using purified IgG at 0.5 mg/ml in the Petri dish assay. Error bars represents standard deviations.](https://figures.cochat.ai/paper-figures/e7fe287f97b942b999706931253f1b21/differential-induction-of-functional-igg-using-the-plasmodium-falciparum-figure-3.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, antibodies to the single DBL4 domain almost completely inhibited the binding of homologous and 2 heterologous IE to CSA [47,48] while antibodies to other single or multi-domain immunogens only reduced homologous parasite binding to CSA by 50–60% [47].”
From Designing a VAR2CSA-based vaccine to prevent placental malaria (2015) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Anti-adhesion antibodies induced by immunization with DBL4 domain of FCR3 allele were species-dependent: anti-adhesion activity was observed in samples collected from immunized rats but not from rabbits [48].”
From Designing a VAR2CSA-based vaccine to prevent placental malaria (2015) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108 · cited 1×
“chondroitin sulfate A (CSA) present on placental syncytiotrophoblast cells located in the intervillous space [9,10].”
BackgroundAn analysis of malaria in pregnancy in Africa.
Brabin, B. J. (1983) · PubMed Central · Cited by 877
Malaria: progress, perils, and prospects for eradication
Greenwood, B. M., Fidock, D. A., Kyle, D. E., Kappe, S. H. I., Alonso, P. L., Collins, F. H., & Duffy, P. E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33996 · Cited by 709
Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702 · cited 1×
“that mediates binding of the IE in the placenta [11,12].”
BackgroundSelf-citationTraggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697 · cited 1×
“Whether this intracellular pool of protein is denatured at the point of schizont rupture, promoting responses in natural infections to flexible loops more tolerant to mutations, as seen in other organisms [36], remains to be investigated.”
BackgroundMaternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659
Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604
Self-citationDavies, D. H., Liang, X., Hernandez, J. E., Randall, A., Hirst, S., Mu, Y., Romero, K. M., Nguyen, T. T., Kalantari-Dehaghi, M., Crotty, S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408782102 · Cited by 417
Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes.
Rogerson, S. J., Chaiyaroj, S. C., Ng, K., Reeder, J. C., & Brown, G. V. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.15 · Cited by 342
Walker, B. D., & Burton, D. R. (2008) · Science · doi:10.1126/science.1152622 · Cited by 338
Tolia, N. H., Enemark, E. J., Sim, B. K. L., & Joshua-Tor, L. (2005) · Cell · doi:10.1016/j.cell.2005.05.033 · Cited by 330
Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain
Singh, S. K., Hora, R., Belrhali, H., Chitnis, C. E., & Sharma, A. (2006) · Nature · doi:10.1038/nature04443 · Cited by 247
Kriek, N., Tilley, L., Horrocks, P., Pinches, R., Elford, B. C., Ferguson, D. J. P., Lingelbach, K., & Newbold, C. I. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03784.x · Cited by 197
Jiménez-Díaz, M. B., Mulet, T., Viera, S., Gómez, V., Garuti, H., Ibáñez, J., Alvarez-Doval, A., Shultz, L. D., Martínez, A., Gargallo-Viola, D., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00519-09 · Cited by 187
High Level of var2csa Transcription by Plasmodium falciparum Isolated from the Placenta
Tuikue Ndam, N. G., Salanti, A., Bertin, G., Dahlbäck, M., Fievet, N., Turner, L., Gaye, A., Theander, T., & Deloron, P. (2005) · The Journal of Infectious Diseases · doi:10.1086/430933 · Cited by 179
Self-citationTrimnell, A. R., Kraemer, S. M., Mukherjee, S., Phippard, D. J., Janes, J. H., Flamoe, E., Su, X.-Z., Awadalla, P., & Smith, J. D. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.03.012 · Cited by 165
Naturally acquired immunity to Plasmodium falciparum malaria in Africa
Hviid, L. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.06.012 · Cited by 163
Srivastava, A., Gangnard, S., Round, A., Dechavanne, S., Juillerat, A., Raynal, B., Faure, G., Baron, B., Ramboarina, S., Singh, S. K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000951107 · Cited by 149
Duffy, M. F., Maier, A. G., Byrne, T. J., Marty, A. J., Elliott, S. R., O’Neill, M. T., Payne, P. D., Rogerson, S. J., Cowman, A. F., Crabb, B. S., et al. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.03.006 · Cited by 126
Khunrae, P., Dahlbäck, M., Nielsen, M. A., Andersen, G., Ditlev, S. B., Resende, M., Pinto, V. V., Theander, T. G., Higgins, M. K., & Salanti, A. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.040 · Cited by 121
Self-citationBarfod, L., Bernasconi, N. L., Dahlbäck, M., Jarrossay, D., Andersen, P. H., Salanti, A., Ofori, M. F., Turner, L., Resende, M., Nielsen, M. A., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05503.x · Cited by 110
Self-citationThe Structure of a Chondroitin Sulfate-binding Domain Important in Placental Malaria
Higgins, M. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800086200 · Cited by 100
Dahlbäck, M., Rask, T. S., Andersen, P. H., Nielsen, M. A., Ndam, N. T., Resende, M., Turner, L., Deloron, P., Hviid, L., Lund, O., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020124 · Cited by 98 · cited 1×
“This is in line with the findings that patches of high sequence diversity in VAR2CSA are concentrated in flexible loops [20,31,32] and that naturally acquired antibodies also are directed against these regions [33].”
ResultSelf-citationTB vaccines: current status and future perspectives
Aagaard, C., Dietrich, J., Doherty, M. T., & Andersen, P. L. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.14 · Cited by 96
Self-citationNielsen, M. A., Pinto, V. V., Resende, M., Dahlbäck, M., Ditlev, S. B., Theander, T. G., & Salanti, A. (2009) · Infection and Immunity · doi:10.1128/iai.00159-09 · Cited by 92 · cited 4×
“Differential recognition of DBL4e in ELISA-peptide array analysis The DBL4e recombinant protein appeared previously to be the only single domain that induces highly inhibitory antibodies [15].”
BackgroundMethodSelf-citationDynamics of Anti‐VAR2CSA Immunoglobulin G Response in a Cohort of Senegalese Pregnant Women
Tuikue Ndam, N. G., Salanti, A., Le‐Hesran, J. ‐., Cottrell, G., Fievet, N., Turner, L., Sow, S., Dangou, J. ‐., Theander, T., & Deloron, P. (2006) · The Journal of Infectious Diseases · doi:10.1086/500146 · Cited by 89
Self-citationStructural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA
Andersen, P., Nielsen, M. A., Resende, M., Rask, T. S., Dahlbäck, M., Theander, T., Lund, O., & Salanti, A. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040042 · Cited by 79 · cited 3×
“The full-length protein VAR2CSA (FV2) and the six VAR2CSA DBL-domains were produced corresponding to the following amino acid number in VAR2CSA: FV2FCR3: 1–2649, DBL1X: 58–438 (380 aa), DBL2X: 538–893 (355 aa), DBL3X: 1210–1587 (377 aa), DBL4e: 1583–1947 (364 aa), DBL5e: 1990–2328 (338 aa) and DBL6e: 2307–2641 (334 aa…”
MethodResultSelf-citationSurh, C. D., Ahmed-Ansari, A., & Gershwin, M. E. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.7.2647 · Cited by 76
VAR2CSA Expression on the Surface of Placenta‐Derived Plasmodium falciparum–Infected Erythrocytes
Magistrado, P., Salanti, A., Tuikue Ndam, N. G., Mwakalinga, S. B., Resende, M., Dahlbäck, M., Hviid, L., Lusingu, J., Theander, T. G., & Nielsen, M. A. (2008) · The Journal of Infectious Diseases · doi:10.1086/591502 · Cited by 61
Self-citationBarfod, L., Nielsen, M. A., Turner, L., Dahlbäck, M., Jensen, A. T. R., Hviid, L., Theander, T. G., & Salanti, A. (2006) · Infection and Immunity · doi:10.1128/iai.01617-05 · Cited by 59
Self-citationHaase, R. N., Megnekou, R., Lundquist, M., Ofori, M. F., Hviid, L., & Staalsoe, T. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.3035-3038.2006 · Cited by 52
Avril, M., Kulasekara, B. R., Gose, S. O., Rowe, C., Dahlbäck, M., Duffy, P. E., Fried, M., Salanti, A., Misher, L., Narum, D. L., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01470-07 · Cited by 51
Self-citationMagistrado, P. A., Minja, D., Doritchamou, J., Tuikue Ndam, N., John, D., Schmiegelow, C., Massougbodji, A., Dahlbäck, M., Ditlev, S. B., Pinto, V. V., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.10.080 · Cited by 49
Self-citationFernandez, P., Viebig, N. K., Dechavanne, S., Lépolard, C., Gysin, J., Scherf, A., & Gamain, B. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-170 · Cited by 43
Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies
Salanti, A., Resende, M., Ditlev, S. B., Pinto, V. V., Dahlbäck, M., Andersen, G., Manczak, T., Theander, T. G., & Nielsen, M. A. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-11 · Cited by 42 · cited 4×
“The level of reactivity in this ELISA based peptide array was directly associated to the level of reactivity in an assay where identical peptides were synthesised directly on to a chip, confirming homogeneous coating of the peptides [17].”
BackgroundMethodResultSelf-citationAvril, M., Cartwright, M. M., Hathaway, M. J., Hommel, M., Elliott, S. R., Williamson, K., Narum, D. L., Duffy, P. E., Fried, M., Beeson, J. G., et al. (2010) · Infection and Immunity · doi:10.1128/iai.00410-09 · Cited by 39
Mapping epitopes and antigenicity by site-directed masking
Paus, D., & Winter, G. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600263103 · Cited by 38
Fernandez, P., Petres, S., Mécheri, S., Gysin, J., & Scherf, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012558 · Cited by 36
Nielsen, M. A., Resende, M., Alifrangis, M., Turner, L., Hviid, L., Theander, T. G., & Salanti, A. (2007) · Experimental Parasitology · doi:10.1016/j.exppara.2007.03.002 · Cited by 33 · cited 1×
“The reactivity of IgG in animal sera to the VAR2CSA protein expressed on IE surface was measured by flow-cytometry (FCM) using a protocol modified from [39].”
MethodSelf-citationVAR2CSA Domains Expressed in Escherichia coli Induce Cross‐Reactive Antibodies to Native Protein
Oleinikov, A. V., Francis, S. E., Dorfman, J. R., Rossnagle, E., Balcaitis, S., Getz, T., Avril, M., Gose, S., Smith, J. D., Fried, M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/529526 · Cited by 31
Guinovart, C., & Alonso, P. L. (2007) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.276 · Cited by 18
Analysis of CSA-Binding Parasites and Antiadhesion Antibodies
Fried, M., & Duffy, P. E. (2003) · Malaria Methods and Protocols · doi:10.1385/1-59259-271-6:555 · Cited by 12
Research works printed but not linked: 1
- 41. Oleinikov AV, Francis SE, Dorfman JR, Rossnagle E, Balcaitis S, et al. (2008) VAR2CSA domains expressed in Escherichia coli induce cross-reactive antibodies to native protein. J Infect Dis 197: 1119-1123. · DOI · Paper page
Cited by
Mordmüller, B., Sulyok, M., Egger-Adam, D., Resende, M., de Jongh, W. A., Jensen, M. H., Smedegaard, H. H., Ditlev, S. B., Soegaard, M., Poulsen, L., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1140 · Cited by 154
Self-citationDesigning a VAR2CSA-based vaccine to prevent placental malaria
Fried, M., & Duffy, P. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.011 · Cited by 86
“Anti-adhesion antibodies induced by immunization with DBL4 domain of FCR3 allele were species-dependent: anti-adhesion activity was observed in samples collected from immunized rats but not from rabbits [48].”
BackgroundProgress and Insights Toward an Effective Placental Malaria Vaccine
Gamain, B., Chêne, A., Viebig, N. K., Ndam, N. T., & Nielsen, M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.634508 · Cited by 46
Self-citationMultilaboratory Approach to Preclinical Evaluation of Vaccine Immunogens for Placental Malaria
Fried, M., Avril, M., Chaturvedi, R., Fernandez, P., Lograsso, J., Narum, D., Nielsen, M. A., Oleinikov, A. V., Resende, M., Salanti, A., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01106-12 · Cited by 38
Self-citationDoritchamou, J. Y. A., Herrera, R., Aebig, J. A., Morrison, R., Nguyen, V., Reiter, K., Shimp, R. L., MacDonald, N. J., Narum, D. L., Fried, M., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw197 · Cited by 35
Metadata
- Authors
- Pinto, V. V., Ditlev, S. B., Jensen, K. E., Resende, M., Dahlbäck, M., Andersen, G., Andersen, P., Theander, T. G., Salanti, A., & Nielsen, M. A.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Nielsen, Morten A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-03-25
- Volume
- 6
- Issue
- 3
- Pages
- e17942
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3064590
- OpenAlex
- W1976268367
- Cited by
- 18
- References
- 43
- Citations by year
- 2024: 1 · 2023: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 3
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Bill and Melinda Gates Foundation (47029)
- European Commission (201222)
- Novo Nordisk
- Novo Nordisk Fonden
- FP7 Health
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Keywords
- placental malaria, VAR2CSA, Plasmodium falciparum, chondroitin sulfate A, C-terminal domain, B-cell epitopes, inhibitory antibodies, erythrocyte adhesion, immunogenicity
- MeSH terms
- Animals, Antibodies, Protozoan, Antibody Formation, Epitopes, Antigens, Protozoan, Enzyme-Linked Immunosorbent Assay, Erythrocytes, Female, Humans, Immunoglobulin G, Placenta, Plasmodium falciparum, Pregnancy, Rabbits, Recombinant Proteins, Species Specificity, Malaria, Falciparum, Protein Structure, Tertiary, Malaria Vaccines, Protein Array Analysis, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.